BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2459513)

  • 1. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional vascular effects of serotonin and ketanserin in young, healthy subjects.
    Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
    Hypertension; 1988 Mar; 11(3):256-63. PubMed ID: 2832328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related.
    Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):14-21. PubMed ID: 2475705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
    Kiowski W; Linder L; Erne P
    J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
    Vanmolkot FH; Van der Schueren BJ; de Hoon JN
    Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration.
    Jacob G; Costa F; Vincent S; Robertson D; Biaggioni I
    Circulation; 2003 May; 107(19):2475-9. PubMed ID: 12707242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
    J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between serotonin and endogenous and exogenous noradrenaline in the human forearm.
    Bruning TA; Chang PC; Blauw GJ; Vermeij P; Van Zwieten PA
    Blood Press; 1994 Sep; 3(5):309-18. PubMed ID: 7866595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.
    Bolli P; Erne P; Ji BH; Block LH; Kiowski W; Bühler FR
    J Hypertens Suppl; 1984 Dec; 2(3):S115-8. PubMed ID: 6100732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-adrenergic and serotonergic mechanisms in the human digit.
    Coffman JD; Cohen RA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S49-53. PubMed ID: 2459515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
    Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
    Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
    Scalbert E; Richer C; Giudicelli JF
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the hemodynamic effects of urapidil and flesinoxan in healthy volunteers.
    Van Zwieten PA; Bruning TA
    Blood Press Suppl; 1994; 4():19-24. PubMed ID: 7804508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of vasoconstriction by insulin.
    van Veen S; Chang PC
    J Hypertens; 1998 Aug; 16(8):1157-64. PubMed ID: 9794720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II evokes potent vasoconstriction in humans in vivo.
    Böhm F; Pernow J
    Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
    Mollace V; De Francesco EA; Fersini G; Nisticò G
    Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelin-induced vasoconstriction in man: variable modification caused by endothelium-derived relaxing factor, Sodium nitroprusside and calcium antagonists].
    Kiowski W; Linder L; Lüscher TF; Bühler FR
    Schweiz Med Wochenschr; 1992 Apr; 122(15):559-62. PubMed ID: 1566022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
    van Lieburg AF; Knoers NV; Monnens LA; Smits P
    J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.